CVM - Cel-Sci Corporation

Day 1m 10m 60m PreMarket Market AfterHours Gap
9.91 0.09 (0.94%) --- --- --- --- 0.15 (1.53%) 0.1 (1.01%) 0.1 (1.01%)

CEL-SCI Corp is a player in the biotechnology sector. It is engaged in the research and development of the treatment of cancer and other diseases using the immune system. The Company's core capabilities include drug discovery, research, development, and manufacturing of complex biological substances. It is focused on the development of Multikine (Leukocyte Interleukin, Injection), investigational immunotherapy under development for the treatment of certain head and neck cancers, and anal warts or cervical dysplasia.

Category: BIOLOGICAL PRODUCTS, (NO DISGNOSTIC SUBSTANCES)
Market Period: Closed

Earnings & Ratios

Basic EPS:
Diluted EPS:
-1.36
Basic P/E:
Diluted P/E:
-7.3529
RSI(14) 1m:
0.0
VWAP:
9.99
RVol:
0.2674

Events

Period Kind Movement Occurred At

Related News